[Protective effect of fosfomycin against aminoglycoside induced ototoxicity].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003982:Dibekacin / Q000009:adverse effects* / Q000378:metabolism; D005578:Fosfomycin / Q000494:pharmacology*; D006198:Hair Cells, Auditory / Q000187:drug effects*; D007612:Kanamycin / Q000031:analogs & derivatives*; D007668:Kidney / Q000032:analysis; D007674:Kidney Diseases / Q000139:chemically induced; D007759:Labyrinth Diseases / Q000139:chemically induced*; D051381:Rats
D000900:Anti-Bacterial Agents; D005578:Fosfomycin; D003982:Dibekacin; D007612:Kanamycin